This Panel took place at LSI Asia ‘25 Emerging Medtech Summit in Singapore.

The LSI Asia ‘25 panel, “Bio-Convergence — The Future of Vision Tech,” explores how the convergence of digital health, biology, and device technology is giving rise to a new generation of vision solutions that blur the lines between diagnostics, therapeutics, and wearable tech, with leading companies redefining what’s possible in ophthalmology and vision restoration.

This panel featured:

Assaf Barnea — CEO, Sanara Ventures

Daria Lemann-Blumenthal — CEO, Nanodrops

Qizhi Linna Fu — VP Operations And General Manager, China & Hong Kong, STAAR Surgical

Enrique Vega — CEO, Azalea Vision

Almog Aley-Raz – CEO & VP R&D, CorNeat Vision

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social:

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw